Event Details

KemPharm® is a clinical stage, specialty pharmaceutical company engaged in the development and discovery of proprietary prodrugs that are designed to be improved versions of widely prescribed and FDA approved products.

KemPharm Inc at the BIO CEO & Investor Conference

Feb 14, 2017 from 11:30 AM to 11:30 AM EST


The Waldorf Astoria